This finding, coupled with clinical observations, suggests an important biological role for CCL2 in CKD onset and progression, although further investigations using cell-specific knockout and other gene-editing strategies in mice are needed to elucidate the specific mechanisms. The gene discussed is CCL2; the disease is chronic kidney disease.